Editor’s Note: Fitness Bullying
Are you guilty of fitness bullying? Are you one of those who makes fun of larger sized individuals while they are trying to exercise? Do you make fun of others…
Sinovac Raises $86.73 Million Through Private Placement Transaction
Vivo Capital and Advantech Capital Each Hold an Approximately 8.3% Stake in Sinovac After the Private Placement Transaction Proceeds Will Be Used to Fund Improvement and Construction of Facilities for…
SAI Global and ERM Forge Global Strategic Partnership to Advance Environmental, Health and Safety Innovation
-Leading EHS software solutions vendor joins forces with global EHS consultant to create an ecosystem of EHS innovation and best practice delivery CHICAGO, July 3, 2018 /PRNewswire/ — SAI Global,…
Neovii & Mundipharma Confirm In-licensing Agreement for the Development and Promotion of Grafalon(R) in China and Japan for Solid Organ & Stem Cell Transplant
SINGAPORE, July 5, 2018 /PRNewswire/ — Neovii pharmaceuticals AG of Rapperswil, Switzerland and Mundipharma have entered into an agreement giving Mundipharma the rights to develop and distribute its polyclonal antibody…
Hg Invests in Orion Health Rhapsody and Population Health Businesses
BOSTON, July 6, 2018 /PRNewswire/ — Orion Health Group Limited (NZX:OHE/ASX:OHE) announced that it has reached an agreement in relation to Orion Health’s Rhapsody and Population Health businesses with Hg,…
#Move8 Weekly Events
Thursdays * 7PM 5KM Walk or Run Arcoris Mont Kiara, Kuala Lumpur Facebook event page Sundays * 5PM 7KM WALK, HIKE OR RUN Kiara Hill, TTDI Kuala Lumpur (Meet at…
New Phadia 200 Advances In-vitro Diagnostics in Europe for Allergy and Autoimmune Conditions
UPPSALA, Sweden, July 6, 2018 /PRNewswire/ — A new benchtop instrument from Thermo Fisher Scientific, the Phadia 200, enables new levels of flexibility and automation for laboratory testing facilities to…
FOREO Announces Appointment of New CEO Filip Sedic
STOCKHOLM, July 7, 2018 /PRNewswire/ — FOREO has announced the appointment of Filip Sedic as Chief Executive Officer to lead the company through its next phase of innovation and spur…
Adlai Nortye Raises $53M in Series B
HANGZHOU, China, July 5, 2018 /PRNewswire/ — Adlai Nortye Biopharma Co., Ltd. (“Adlai Nortye” or “the Company”), a biopharmaceutical company, announced that it has raised $53 million in a Series…
JHL Biotech Announces China Approves Clinical Trial Rituximab Biosimilar to Treat Non-Hodgkin Lymphoma
HSINCHU and WUHAN, July 6, 2018 /PRNewswire/ — JHL Biotech announced today that the Center for Drug Evaluation (CDE), State Drug Administration of China (SDA) has approved JHL’s Phase I…
